Vile R - Search Results

1

Measles virus causes immunogenic cell death in human melanoma.

Donnelly OG, Errington-Mais F, Steele L, Hadac E, Jennings V, Scott K, Peach H, Phillips RM, Bond J, Pandha H, Harrington K, Vile R, Russell S, Selby P, Melcher AA. Donnelly OG, et al. Among authors: vile r. Gene Ther. 2013 Jan;20(1):7-15. doi: 10.1038/gt.2011.205. Epub 2011 Dec 15. Gene Ther. 2013. PMID: 22170342 Free PMC article.

2

Gene transfer technologies for the gene therapy of cancer.

Vile R, Russell SJ. Vile R, et al. Gene Ther. 1994 Mar;1(2):88-98. Gene Ther. 1994. PMID: 7584073 Review.

3

Retroviruses as vectors.

Vile RG, Russell SJ. Vile RG, et al. Br Med Bull. 1995 Jan;51(1):12-30. doi: 10.1093/oxfordjournals.bmb.a072941. Br Med Bull. 1995. PMID: 7767638 Review.

4

A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model.

Castleden SA, Chong H, Garcia-Ribas I, Melcher AA, Hutchinson G, Roberts B, Hart IR, Vile RG. Castleden SA, et al. Among authors: vile rg. Hum Gene Ther. 1997 Nov 20;8(17):2087-102. doi: 10.1089/hum.1997.8.17-2087. Hum Gene Ther. 1997. PMID: 9414257

5

Genetic prodrug activation therapy.

Martin LA, Vile R, Lemoine NR, Sikora K, Pandha HS. Martin LA, et al. Among authors: vile r. Lancet. 1997 Dec 20-27;350(9094):1793-4. doi: 10.1016/s0140-6736(05)63633-1. Lancet. 1997. PMID: 9428248 No abstract available.

6

Gene therapy for cancer--managing expectations.

Melcher AA, Garcia-Ribas I, Vile RG. Melcher AA, et al. Among authors: vile rg. BMJ. 1997 Dec 13;315(7122):1604-7. doi: 10.1136/bmj.315.7122.1604. BMJ. 1997. PMID: 9437283 Free PMC article. Review. No abstract available.

7

Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity.

Chong H, Todryk S, Hutchinson G, Hart IR, Vile RG. Chong H, et al. Among authors: vile rg. Gene Ther. 1998 Feb;5(2):223-32. doi: 10.1038/sj.gt.3300584. Gene Ther. 1998. PMID: 9578842

8

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression.

Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. Melcher A, et al. Among authors: vile rg. Nat Med. 1998 May;4(5):581-7. doi: 10.1038/nm0598-581. Nat Med. 1998. PMID: 9585232

9

Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Todryk SM, Chong H, Vile RG, Pandha H, Lemoine NR. Todryk SM, et al. Among authors: vile rg. Gut. 1998 Oct;43(4):445-9. doi: 10.1136/gut.43.4.445. Gut. 1998. PMID: 9824562 Free PMC article.

10

Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity.

Melcher A, Todryk S, Bateman A, Chong H, Lemoine NR, Vile RG. Melcher A, et al. Among authors: vile rg. Cancer Res. 1999 Jun 15;59(12):2802-5. Cancer Res. 1999. PMID: 10383135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters